Subscribe for updates

CSE:PREV $0.02

About Us
Our Lead Program
Investors
Media Centre
- In the Media
Contact Us
- Contact Details
- Request for Information

Search

About Us
Our Lead Program
Investors
Media Centre
- In the Media
Contact Us
- Contact Details
- Request for Information

Search

CSE: PREV $0.02

In the Media

Media Centre

In the Media

December 16, 2024 PreveCeutical Medical advances gene therapy with BioGene Therapeutics to target diabetes and obesity

Keep up to date with our company updates

About Us
Our Lead Program
Investors
Media Centre
- In the Media
Contact Us
- Contact Details
- Request for Information

©2026 BioGene Therapeutic Privacy Policy

Designed and Powered by BLENDER

Close

I consent

I agree to and consent to receive news, updates, and other communications by way of commercial electronic messages (including email) from BioGene Therapeutic. I understand I may withdraw consent at any time by clicking the unsubscribe link contained in all emails from BioGene Therapeutic.

[email protected]